Neuroprotective effects of antidepressant and mood stabilizing drugs

Journal of Psychiatry and Neuroscience

Volumn 27, Issue 1, 2002, Pages 8-9

  Young, L Trevor ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antidepressive agents; Bipolar disorder; Brain derived neurotrophic factor; Depressive disorder; Lithium; Models, animal; Neuroprotective agents

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM;

AFFECTIVE NEUROSIS; BRAIN CORTEX; BRAIN SIZE; CELL LOSS; CELL PROTECTION; COGNITIVE DEFECT; DENTATE GYRUS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; ELECTROCONVULSIVE THERAPY; GENE EXPRESSION; GLIA CELL; HIPPOCAMPUS; HUMAN; LONG TERM CARE; NERVE CELL CULTURE; NERVE CELL LESION; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TERATOGENICITY;

AMYGDALA; ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; HIPPOCAMPUS; MOOD DISORDERS; RATS;

EID: 0036247091     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents
2. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
3. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
4. Enhancement of hippocampal neurogenesis by lithium
5. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS
6. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine
7. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx
8. Long-term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity
9. +
10. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
11. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines
12. The teratogenicity of anticonvulsant drugs
13. Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder
14. Subgenual prefrontal cortex abnormalities in mood disorders
15. Glial reduction in the subgenual prefrontal cortex in mood disorders
16. Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression
17. fMRI during affect discrimination in bipolar affective disorder
18. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: An MRI study demonstrating neuroanatomic specificity
19. The functional neuroanatomy of mood disorders
20. Brain magnetic resonance imaging of structural abnormalities in bipolar disorder
21. Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication
22. Lithium-induced increase in human brain grey matter